Document is current
Any future updates will be listed below
-
Authors
Lynch, Olivia F.
Witt, Emily E.
Fernandez, Alicia
Rodriguez, Jeslyn A.
Montoya Rubiano, Maria Alejandra
Burstin, Helen
Sheridan, Susan
Hightower, Maia
Bates, David W.
Johnson, Kevin B.
Bergmark, Regan W.
Ortega, Gezzer
-
Funding
Funding for this research was provided by:
NIH NIMHD (K23MD016129)
- License Information
-
More Information
Article History
Received: 24 September 2025
Accepted: 6 May 2026
First Online: 15 May 2026
Competing interests
: R.W.B. discloses unrelated clinical trial grant funding from I-Mab Biopharma and unrelated research consulting funding from Analysis Group. D.W.B. has received consulting fees and/or stock options from AESOP, FeelBetter, Guided Clinical Solution, ValeraHealth, Clew, and MDClone, as well as consulting fees from Relyens, all outside the submitted work. All other authors declare no competing interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
